Palmer SM - Search Results

1

Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Garantziotis S, Palmer SM, Snyder LD, Ganous T, Chen BJ, Wang T, Cook DN, Schwartz DA. Garantziotis S, et al. Among authors: palmer sm. Transplantation. 2007 Oct 27;84(8):1012-9. doi: 10.1097/01.tp.0000286040.85007.89. Transplantation. 2007. PMID: 17989607 Free PMC article.

2

Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL. Palmer SM, et al. Transplantation. 2002 Sep 27;74(6):799-804. doi: 10.1097/00007890-200209270-00011. Transplantation. 2002. PMID: 12364858

3

The role of innate immunity in acute allograft rejection after lung transplantation.

Palmer SM, Burch LH, Davis RD, Herczyk WF, Howell DN, Reinsmoen NL, Schwartz DA. Palmer SM, et al. Am J Respir Crit Care Med. 2003 Sep 15;168(6):628-32. doi: 10.1164/rccm.200303-447OC. Epub 2003 May 28. Am J Respir Crit Care Med. 2003. PMID: 12773319

4

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.

Drew RH, Dodds Ashley E, Benjamin DK Jr, Duane Davis R, Palmer SM, Perfect JR. Drew RH, et al. Among authors: palmer sm. Transplantation. 2004 Jan 27;77(2):232-7. doi: 10.1097/01.TP.0000101516.08327.A9. Transplantation. 2004. PMID: 14742987 Clinical Trial.

5

Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.

Palmer SM, Grinnan DC, Diane Reams B, Steele MP, Messier RH, Duane Davis R. Palmer SM, et al. Clin Transplant. 2004 Apr;18(2):179-85. doi: 10.1046/j.1399-0012.2003.00152.x. Clin Transplant. 2004. PMID: 15016133

6

Innate immunity influences long-term outcomes after human lung transplant.

Palmer SM, Burch LH, Trindade AJ, Davis RD, Herczyk WF, Reinsmoen NL, Schwartz DA. Palmer SM, et al. Am J Respir Crit Care Med. 2005 Apr 1;171(7):780-5. doi: 10.1164/rccm.200408-1129OC. Epub 2005 Jan 7. Am J Respir Crit Care Med. 2005. PMID: 15640363

7

Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation.

Hartwig MG, Patel V, Palmer SM, Cantu E, Appel JZ, Messier RH, Davis RD. Hartwig MG, et al. Among authors: palmer sm. Transplantation. 2005 Aug 15;80(3):320-5. doi: 10.1097/01.tp.0000165858.86067.a2. Transplantation. 2005. PMID: 16082326

8

Quality, quantity, or both? Life after lung transplantation.

Snyder LD, Palmer SM. Snyder LD, et al. Among authors: palmer sm. Chest. 2005 Sep;128(3):1086-7. doi: 10.1378/chest.128.3.1086. Chest. 2005. PMID: 16162687 No abstract available.

9

Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.

Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA. Palmer SM, et al. Clin Transplant. 2006 Jan-Feb;20(1):30-6. doi: 10.1111/j.1399-0012.2005.00436.x. Clin Transplant. 2006. PMID: 16556150

10

Successful bilateral lung transplant outcomes in recipients 61 years of age and older.

Palmer SM, Davis RD, Simsir SA, Lin SS, Hartwig M, Reidy MF, Steele MP, Eu PC, Blumenthal JA, Babyak MA. Palmer SM, et al. Transplantation. 2006 Mar 27;81(6):862-5. doi: 10.1097/01.tp.0000203298.00475.0d. Transplantation. 2006. PMID: 16570009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters